research Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
This study found that EGFR-targeted cancer therapy can cause skin toxicities by disrupting epidermal signaling, allowing microbiota invasion and inflammation, but identified a potential treatment approach using FGF7 or SOS expression to restore barrier integrity.